SD Biosensor, Inc (KRX:137310)

Market Cap	1.14T
Revenue (ttm)	694.57B
Net Income (ttm)	-98.41B
Shares Out	116.89M
EPS (ttm)	-805.31
PE Ratio	n/a
Forward PE	n/a
Dividend	200.00 (2.08%)
Ex-Dividend Date	Dec 27, 2024

Volume	97,198
Average Volume	185,865
Open	9,620.00
Previous Close	9,600.00
Day's Range	9,570.00 - 9,810.00
52-Week Range	7,870.00 - 15,340.00
Beta	0.87
RSI	34.09
Earnings Date	Mar 26, 2025

About SD Biosensor

SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decis...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 576
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 137310

Financial Performance

In 2024, SD Biosensor's revenue was 694.57 billion, an increase of 5.93% compared to the previous year's 655.68 billion. Losses were -98.41 billion, -78.96% less than in 2023.